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Peripheral intravenous catheters (PIVCs) are the most widely used invasive devices world-
wide. Up to 42% of PIVCs are prematurely removed during intravenous therapy due to fail-
ure. To date, there have been few systematic attempts in European hospitals to measure
adherence to recommendations to mitigate PIVC failures.
Aim
To analyse the clinical outcomes from clinical practice guideline recommendations for PIVC
care on different hospital types and environments.
Methods
We conducted an observational study in three hospitals in Spain from December 2017 to
April 2018. The adherence to recommendations was monitored via visual inspection in situ
evaluations of all PIVCs inserted in adults admitted. Context and clinical characteristics
were collected by an evaluation tool, analysing data descriptively.
Results
646 PIVCs inserted in 624 patients were monitored, which only 52.7% knew about their
PIVC. Regarding PIVC insertion, 3.4% (22/646) patients had at least 2 PIVCs simulta-
neously. The majority of PIVCs were 20G (319/646; 49.4%) and were secured with transpar-
ent polyurethane dressing (605/646; 93.7%). Most PIVCs (357/646; 55.3%) had a free
insertion site during the visual inspection at first sight. We identified 342/646 (53%) transpar-
ent dressings in optimal conditions (clean, dry, and intact dressing). PIVC dressings in medi-
cal wards were much more likely to be in intact conditions than those in surgical wards (234/
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399, 58.7% vs. 108/247, 43.7%). We identified 55/646 (8.5%) PIVCs without infusion in the
last 24 hours and 58/646 (9.0%) PIVCs without infusion for more than 24 hours. Regarding
PIVC failure, 74 (11.5%) adverse events were identified, all of them reflecting clinical mani-
festation of phlebitis.
Conclusions
Our findings indicate that the clinical outcome indicators from CPG for PIVC care were mod-
erate, highlighting differences between hospital environments and types. Also, we observed
that nearly 50% of patients did not know what a PIVC is.
Background
Peripheral intravenous catheters (PIVCs) are among the most frequently used vascular access
devices worldwide [1], with their insertion being one of the most common practices for hospi-
tal nurses. PIVCs are indicated for short-term use, usually around a week, for the administra-
tion of intravenous therapy [2]. It is estimated that physicians and nurses insert more than 330
million PIVCs annually in the United States [1, 3]. However, up to 42% of these catheters are
prematurely removed during intravenous therapy due to PIVC failure [4], which is defined as
the unplanned removal of the device due to mechanical complications (i.e., phlebitis, occlu-
sion, infiltration) or infection before the completion of scheduled intravenous therapy [5, 6].
These complications are concerning in their own right, as catheter-related bloodstream infec-
tions (CRBSIs) are one of the most severe adverse events [7, 8], which can prolong hospital
stay, resulting in attributable mortality rates of up to 25% [9, 10], and leading to unnecessary
costs of approximately $45,000 per infection [5, 7].
In the last decade, healthcare systems have focused on reducing the variability of healthcare
practice [11], implementing strategies to integrate the best recommendations of clinical prac-
tice guidelines (CPG) in combination with professional experience and user preferences [12–
14], to provide optimally and quality care to patients [15]. However, introducing innovations
such as the recommendations endorsed by CPGs onto routine clinical practice remains a com-
plex and arduous process that is not exempt from difficulties [16]. For example, the number of
CPG has grown significantly to the extent of being unmanageable [17]. Another critical chal-
lenge is the frequent tardiness in the implementation of these recommendations into clinical
practice, probably fuelled by perceptions of clinical experience as the main element in deci-
sion-making [18]. Despite efforts to reduce the research-practice gap, some studies suggest
that 30–40% of patients still do not receive healthcare based on the best available evidence [19–
21], suggesting the difficulty of its implementation [22].
This gap is a complex and multifaceted phenomenon, which requires a deep understanding
of decision-making [18]. The use of a knowledge mobilization model could counteract this sit-
uation, including strategies to promote fidelity to recommendations, audit and feedback of
compliance and health literacy of vascular access, as crucial elements of a multimodal interven-
tion [23]. Such gap is, therefore, a significant threat to patient safety and healthcare efficiency
[24, 25]. To date, there have been few systematic attempts to measure the adherence to recom-
mendations regarding optimal PIVC care and to mitigate PIVC failures in European hospitals.
Therefore, the purpose of this study was to analyse the clinical outcome indicators from CPG
for the insertion, maintenance, and management of PIVCs on different hospital types and
environments.
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Methods
We used the Strengthening the Reporting of Observational Studies in Epidemiology
(STROBE) statement for the reporting of observational studies to assist the reporting of our
results.
Study design and participants
We performed a prospective multicentre observational study, where data collectors directly
observed the PIVC in situ. We conducted the study in all hospital wards of three hospitals in
Mallorca (Spain). Hospital 1 and Hospital 2 are public-funded acute care hospitals and serve a
population of 150.000 and 130.000 inhabitants. These hospitals have 224 and 165-bed hospitals
respectively, for all clinical specialities except cardiac, thoracic, and neurosurgery. Hospital 3 is
a long-term care hospital and has 197 hospital beds, of which 117 are intended for the treat-
ment of chronic disease and palliative population.
We used the convenience sampling method and included all adult patients (18-years or
older admitted to any hospital wards of the three hospitals), who have one or more PIVCs in
situ on the day the researchers were present via unannounced. Emergency, critical care, paedi-
atric, maternity, perioperative, and operating room areas were excluded in the analysis of the
adherence to recommendations, as PIVCs in those areas are routinely maintained for less than
24 hours.
Data collection
We collected data using a case report form that we had developed to analyse the clinical out-
comes for the care of PIVC from clinical practice guidelines recommendations [26, 27].
Table 1 describes the recommendations and their clinical outcome indicators.
The case report form consisted of 20-items constructed in 5 sections to respond to the rec-
ommendations and validated by the Content Validity Index [28] for items (I-CVI) and scales
(S-CVI). The items were rated on a 4-point relevance scale, considering 3 or 4 as relevant. The
score results of I-CVI and S-CVI were 0.97 and 0.90, respectively, suggesting a very high con-
tent validity. S1 Table offers the results of the CVI on the 20-item case report form by six clini-
cal experts.
The data collection was conducted from December 2017 to April 2018 by six external
researchers to the hospital. All of them were intentionally selected for their expertise and train-
ing in the management of vascular access and had more than 5-years of employment as regis-
tered nurses. The external researchers received one-week of face-to-face training and a
protocol for completing the case report form. Also, they completed a full working day evalua-
tion with a mentor before starting the study. These standards homogenised the responses,
minimising the potential bias during the study period. The researchers also collected informa-
tion about context characteristics (gender, age years, education, and years employed by regis-
tered nurses). We considered these characteristics as variables that influencing the adherence
to CPG recommendations.
PIVC care and maintenance
Nurses inserted and maintained all PIVCs following the existing hospital policy, being like
CPG recommendations. In summary, skin preparation before insertion was carried out with
2% chlorhexidine in 70% isopropyl alcohol. All PIVCs were Introcan SafetyTM (non-winged)
catheters (B. Braun), with a needle-free valve directly connected to 10cm of extension tubing
ending in a three-way connector (Becton Dickinson). A transparent dressing with
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polyurethane borders (TegadermTM, 3M) was applied at the insertion site to secure the PIVC
in situ. Standard caps on all needleless connectors were in place to minimise accidental tubing
disconnections.
Ethical considerations
The research ethic committee of Hospital Manacor and Balearic Islands approved this study
(IB3492/17PI). All patients were informed about the purpose of the study and their implica-
tions. We obtained oral consent from patients or their legal guardian (in the case of patients
with cognitive impairment) before study participation. Patients who accepted to participate in
the study were progressively included during the study period. No patient refused to partici-
pate in the study.
Statistical analysis
The statistical analysis included a description of the sample (continuous data represented by
means and standard deviation, and categorical data represented by frequency and percentage),
and bivariate analysis with parametric and non-parametric tests, depending on the nature of
the distributions (correlation, ANOVA, chi-square). Data were analysed using SPSS IBM Sta-
tistics version 25.
Table 1. Selection of the indicators for the care of peripheral intravenous catheters from clinical practice guideline recommendations.
Sections Indicators Clinical practice guideline recommendations
Catheter adequacy and
insertion
1. Intravenous cannula size, n (%): 16/18/20/22/24 gauge. Selection of the appropriate peripheral intravenous catheter insertion
site, assessing risks for infection, against the risks of mechanical
complications and patient comfort.
2. Insertion site, n (%): dorsum of hand /wrist /forearm/ antecubital
fossa/upper arm/foot.
3. Indwelling time, n (%): less 48 hours/between 48–96 hours/more
96 h.
Use of the upper extremity, preferably the forearm for peripheral
intravenous catheter insertion unless medically contraindicated.
Catheter and catheter site
care
4. Dressing type, n (%): Sterile transparent bordered semi-permeable
polyurethane / Sterile gauze.
Use of a sterile, transparent, semi-permeable polyurethane dressing
to cover the intravascular insertion site.
5. Dressing integrity, n (%): Poor / Perfect. Change of transparent, semi-permeable polyurethane dressings every
7 days, or sooner, if it is no longer intact or if moisture collects under
the dressing.
6. Causes of poor integrity, n (%): Not intact / Not clean / Not dry /
Hematic residues.
7. Acknowledgement of PIVC, n (%): Yes / No Patient education on treatment targets, administration, infusion,
associated complications, care and management of the catheter.
Catheter removal and
replacement strategies
8. Visual inspection of insertion site, at first sight, n (%): Not visible/
Visible.
Inspection of the peripheral intravenous catheter insertion site at a
minimum during each shift, recording the Visual Infusion Phlebitis
score and/or infiltration score.9. PIVC securement, n (%): Not securement / Tubular mesh / Elastic
bandage / Steri-strip / Medical tape.
10. Securement hinders the visualization of insertion site, n (%): Yes
/ No.
11. Presence of adverse event during the visual inspection, n (%): No
/ Persistent pain / Erythema and swelling / Palpable thrombosis /
Deep venous thrombosis / Not defined.
Surveillance for the occurrence of unexplained fever or pain at the
insertion site, examining for the occurrence of redness, erythema, or
inflammation.
Removal of the peripheral intravenous catheter when complications
occur, or as soon as it is no longer required.
12. Infusion type, n (%): Continuous infusion / Intermittent Infusion
/ In bolus / No infusion in less than 24 hours / No infusion for more
than 24 h.
Removal of the unnecessary peripheral intravenous catheter, when




13. Presence of PIVC insertion records, n (%): Yes / No. Record of peripheral intravenous catheter insertion, including
assessment of insertion site and functionality.
14. Dressing date recorded, n (%): Yes / No. Documentation of peripheral intravenous catheter insertion or
maintenance date at the transparent dressing.
https://doi.org/10.1371/journal.pone.0240086.t001
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Results
Characteristics of the context
Thirteen hospital wards participated in this study, of which 5/13 (38.4%) from hospital 1 and 3,
and 3/13 (23.1%) from hospital 2. Most wards were medical (9/13; 69.2%). One hundred fifty-
eight nurses participated in the study, of whom 139 (88%) were female nurses between 31 to 40
years old and 11 to 20 years employed as a registered nurse. During the development of the study,
we analysed 624 patients, again mainly from medical wards (393; 63%). There were 265/624
(42.5%) female patients, with a mean age of 71.0 years (SD, 14.8 years). In our sample, 474 patients
(76%) did not present cognitive impairment. Among these, 250 patients (52.7%) recognized and
identified the inserted PIVC. We observed significant differences between the characteristics of
context, nurses’ age (p< 0.001), professional experience (p< 0.001), patient age (p = 0.005),
patient cognitive impairment (p< 0.001), and acknowledgement of inserted PIVC (p< 0.001)
comparing hospital types. Also, there were statistically significant differences between nurses’ age
(p = 0.017), and acknowledgement of inserted PIVC (p< 0.001) comparing hospital environ-
ments. All variables associated with characteristics of context are described in Table 2.
Table 2. Comparative analysis of characteristics of context.
Characteristics of context Overall Hospital types Hospital environments
Hospital 1 Hospital 2 Hospital 3 p-value Medical ward Surgical ward p-value
Total wards, n (%) 13 (100) 5 (38.4) 3 (23.1) 5 (38.4) 9 (69.2) 4 (30.8)
Total nurses, n (%) 158 (100) 60 (38.0) 44 (27.8) 54 (34.2) 124 (78.5) 34 (21.5)
Nurses gender, n (%) 0.444 0.255
Female 139 (88.0) 52 (86.8) 41 (93.2) 46 (85.2) 111 (89.5) 28 (82.4)
Male 19 (12.0) 8 (13.3) 3 (6.8) 8 (14.8) 13 (10.5) 6 (17.6)
Nurses age (years), n (%) < 0.001 0.017
21–25 19 (12.0) 5 (8.3) 0 14 (26.0) 12 (9.7) 7 (20.6)
26–30 46 (29.1) 19 (31.7) 6 (13.6) 21 (38.9) 37 (29.8) 9 (26.5)
31–40 77 (48.7) 30 (50.0) 32 (72.7) 15 (27.8) 65 (52.4) 12 (35.6)
41–50 14 (8.9) 6 (10.0) 4 (9.1) 4 (7.4) 10 (8.1) 4 (11.8)
50–60 2 (1.3) 0 2 (4.5) 0 0 2 (5.9)
Nurses academic level 0.293 0.425
Bachelor Nurse 152 (96.2) 56 (93.3) 44 (100) 52 (96.3) 118 (95.2) 34 (100)
Master of Science 6 (3.8) 4 (6.6) 0 2 (3.7) 6 (4.8) 0
Years employed as nurse <0.001 0.787
0–5 42 (26.6) 2 (3.3) 4 (9.1) 36 (66.7) 32 (25.8) 10 (29.5)
6–10 31 (19.6) 7 (11.7) 11 (25.0) 13 (24.1) 23 (18.5) 8 (23.5)
11–20 61 (38.6) 29 (48.3) 27 (61.4) 5 (9.2) 48 (38.7) 13 (38.2)
21–30 24 (15.2) 22 (36.7) 2 (4.5) 0 21 (16.9) 3 (8.8)
Total patients, n (%) 624 (100) 277 (63.0) 211 (37.0) 158 (37.0) 393 (63.0) 231 (37.0)
Patient gender, n (%) 0.340 0.750
Female 265 (42.5) 110 (42.0) 81 (39.3) 74 (47.1) 165 (26.5) 100 (16.0)
Male 359 (57.5) 152 (58.0) 124 (60.7) 83 (52.9) 228 (36.5) 131 (21.0)
Patient age (years), mean (SD) 71.0 (14.8) 69.1 (15.4) 71.7 (12.4) 73.1 (16.1) 0.005 72.6 (14.5) 68.2 (14.7) 0.184
Cognitive impairment, n (%) < 0.001 0.098
Yes 150 (24.0) 40 (15.3) 66 (32.2) 44 (28.0) 103 (16.5) 47 (7.5)
No 474 (76.0) 222 (84.7) 139 (67.8) 113 (72.0) 290 (46.5) 184 (29.5)
Acknowledgement of PIVC < 0.001 <0.001
No 224 (47.3) 108 (48.6) 52 (37.4) 64 (56.6) 161 (55.5) 63 (34.2)
Yes 250 (52.7) 114 (51.4) 87 (62.6) 49 (43.4) 129 (44.5) 121 (65.8)
https://doi.org/10.1371/journal.pone.0240086.t002
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Clinical characteristics and outcomes of the sample
During the development of the study, we analysed 646 PIVCs in situ from 624 patients, of
which had at least 1 PIVC (96.6%), and 22 patients had 2 PIVCs (3.4%). A high number of
PIVCs (274/646; 42.4%) were inserted in a non-flexure anatomical site, such as the forearm,
inserted mostly from the hospital ward (347/646, 53.7%). In terms of catheter size, the majority
were 20G (319/646, 49.4%). A high proportion of PIVCs (373/646, 57.7%) had been in situ for
less than 48 hours at the time of the evaluation. There were statistically significant differences
between the hospital environments regarding total PIVC in situ per patient (p = 0.001), inser-
tion site (p = 0.005), cannula size (p< 0.001), indwelling time (p< 0.001) and setting of inser-
tion (p<0.001). Also, there were statistically significant differences between the hospital types
regarding total PIVC in situ per patient (p = 0.026), insertion site (p< 0.001), cannula size
(p< 0.001), indwelling time (p = 0.023) and setting of insertion (p<0.001). All variables asso-
ciated with clinical characteristics and outcomes are described in Table 3.
Table 3. Clinical characteristics of the sample.
Clinical characteristics Overall Hospital types Hospital environments
Hospital 1 Hospital 2 Hospital 3 p-value Medical ward Surgical ward p-value
Total PIVCs, n (%) 646 (100) 277 (42.9) 211 (32.7) 158 (24.4) 399 (61.8) 247 (38.2)
Total PIVC in situ / patient 0.026 0.001
1 PIVC 624 (96.6) 262 (94.6) 205 (97.2) 157 (99.4) 393 (98.5) 231 (93.5)
2 PIVC 22 (3.4) 15 (5.4%) 6 (2.8) 1 (0.6) 6 (1.5) 16 (6.5)
Insertion site, n (%) < 0.001 0.005
Hand 154 (23.8) 64 (23.1) 46 (21.8) 44 (27.8) 82 (12.7) 72 (11.1)
Wrist 83 (12.8) 28 (10.1) 21 (10.0) 34 (21.5) 51 (7.9) 32 (5.0)
Forearm 274 (42.4) 114 (41.2) 96 (45.5) 64 (40.5) 186 (28.8) 88 (13.6)
Antecubital fossa 114 (17.6) 67 (24.2) 42 (19.9) 5 (3.2) 62 (9.6) 52 (8.0)
Arm 16 (2.5) 3 (1.1) 6 (2.8) 7 (4.4) 14 (2.2) 2 (0.3)
Foot 5 (0.8) 1 (0.4) 0 4 (2.5) 4 (0.6) 1 (0.2)
IV cannula size, n (%) < 0.001 < 0.001
16 gauge 3 (0.5) 0 0 3 (1.9) 0 3 (0.5)
18 gauge 137 (21.2) 57 (20.6) 43 (20.4) 37 (23.4) 42 (6.5) 95 (14.7)
20 gauge 319 (49.4) 146 (52.7) 104 (49.3) 69 (43.7) 223 (34.5) 96 (14.9)
22 gauge 94 (14.6) 19 (6.9) 31 (14.7) 44 (27.8) 68 (10.5) 26 (4.0)
24 gauge 3 (0.5) 1 (0.4) 2 (0.9) 0 2 (0.3) 1 (0.2)
Unevaluated 90 (13.9) 54 (19.5) 31 (14.7) 5 (3.2) 64 (9.9) 26 (4.0)
Indwelling time 0.023 < 0.001
< 48 hours 373 (57.7) 168 (60.6) 105 (49.8) 100 (63.3) 208 (52.1) 165 (66.8)
48–96 hours 138 (21.4) 62 (22.4) 49 (23.2) 27 (17.1) 90 (22.6) 48 (19.4)
> 96 hours 135 (20.9) 47 (17.0) 57 (27.0) 31 (19.6) 101 (25.3) 34 (13.8)
Setting of Insertion, n (%) < 0.001 < 0.001
Hospital Ward 347 (53.7) 120 (43.3) 101 (47.9) 127 (80.4) 261 (42.5) 86 (13.3)
Operating room 80 (12.4) 29 (10.5) 23 (10.9) 28 (17.7) 1 (0.2) 79 (12.2)
Emergency dep. 177 (37.4) 103 (37.2) 74 (35.1) 0 111 (18.1) 66 (10.2)
Intensive Care unit 2 (0.3) 0 2 (0.9) 0 2 (0.3) 0
Ambulatory unit 2 (0.3) 0 2 (0.9) 0 0 2 (0.3)
Primary care 6 (0.9) 2 (0.7) 2 (0.9) 1 (0.6) 4 (0.7) 2 (0.3)
Not registered 32 (5.0) 23 (8.3) 7 (3.3) 2 (1.3) 20 (3.1) 12 (1.9)
https://doi.org/10.1371/journal.pone.0240086.t003
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Table 4 offers all information of PIVC indicators from clinical guideline by hospital types
and settings. The insertion site must be freely inspected at first sight and, at minimum, during
each shift or administration of intravenous therapy for successful PIVC maintenance. These
requirements were the case for most PIVCs (357/646; 55.3%). All visible PIVCs (605/646;
93.7%) had a transparent bordered polyurethane dressing while the rest (41/646; 6.3%) were
not visible. Also, a higher number of PIVCs (231/646; 35.9%) had two or more types of secure-
ment, and 79/646 (12.2%) were entirely covered by an elastic bandage. There were statically
significant differences between hospital types regarding visualization at first sight (p< 0.001)
and PIVC securement preventing such visualization of the insertion site (p = 0.002). However,
there were no statically significant differences between these same outcomes comparing the
hospital environments.
Table 4. Comparative analysis of PIVC indicators from clinical guideline by hospital types and settings.
Variables Overall Hospital types Hospital environments
Hospital 1 Hospital 2 Hospital 3 p-value Medical ward Surgical ward p-value
Total PIVCs, n (%) 646 (100) 277 (42.9) 211 (32.7) 158 (24.4) 399 (61.8) 247 (38.2)
Visual inspection of insertion site, at first sight, n (%) < 0.001 0.935
Not visible 289
(44.7)
143 (51.6) 101 (47.9) 45 (28.5) 179 (44.9) 110 (44.5)
Visible 357
(55.3)
134 (48.4) 110 (52.1) 113 (71.5) 220 (55.1) 137 (55.5)




254 (91.7) 200 (94.8) 151 (95.6) 363 (91.5) 240 (97.2)
Gauze 0 0 0 0 0 0
Not visible 41 (6.3) 23 (8.3) 11 (5.2) 7 (2.8) 34 (8.5) 7 (2.8)
Dressing integrity, n (%) < 0.001 < 0.001
Poor 222
(34.4)
112 (40.4) 60 (28.4) 49 (31.0) 103 (25.8) 118 (47.8)
Perfect (clean, dry and intact) 341
(52.8)
122 (44.0) 134 (63.5) 86 (54.4) 234 (58.7) 108 (43.7)
Unevaluated 83 (12.8) 43 (15.5) 17 (8.1) 23 (14.6) 62 (15.5) 21 (8.5)
Causes of poor integrity, n (%) 0.068 < 0.001
Not intact 42 (19.0) 22 (19.6) 11 (18.3) 9 (18.4) 11 (10.7) 31 (26.3)
Not clean 11 (5.0) 2 (1.8) 6 (10.0) 3 (6.1) 9 (8.7) 2 (1.7)
Not dry 32 (14.5) 11 (9.8) 15 (25.0) 6 (12.2) 21 (20.4) 11 (9.3)
Hematic residues 76 (34.4) 37 (33.0) 18 (30.0) 21 (42.9) 41 (39.8) 35 (29.7)
Two or more 60 (27.1) 40 (35.7) 10 (16.7) 10 (20.4) 21 (20.4) 39 (33.0)
PIVC securement, n (%) < 0.001 < 0.001
Not securement 70 (10.8) 19 (6.9) 21 (10.0) 30 (19.0) 44 (11.0) 26 (10.5)
Tubular mesh 125
(19.3)
52 (18.8) 60 (28.4) 13 (8.2) 120 (30.1) 5 (2.0)
Elastic bandage 79 (12.2) 33 (11.9) 19 (9.0) 27 (17.1) 66 (16.5) 13 (5.3)
Steri-strip 80 (12.4) 25 (9.0) 26 (12.3) 29 (18.4) 28 (7.0) 52 (21.1)
Medical tape 61 (9.4) 5 (1.8) 43 (20.4) 13 (8.2) 47 (11.8) 14 (5.7)
Two or more 231
(35.9)
143 (51.6) 42 (19.9) 46 (29.1) 94 (23.6) 137 (55.4)
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Regarding the clinical outcome indicators from CPG for the maintenance recommenda-
tions, we identified 341/646 (52.8%) transparent dressings in perfect conditions (defined as a
clean, dry, and intact dressing). PIVC dressings in medical wards were much more likely to be
in perfect conditions than those in surgical wards (234/399; 58.7% vs. 108/247; 43.7%). The
most frequent defect seen in the dressings was the presence of blood traces or residues (76/
221; 34.4%) inside the transparent dressing membrane or the combination of two or more
conditions, such as not intact, not dry, or not clean (60/221; 27.1%). The variables related to
dressing type (p = 0.004), integrity (p< 0.001), causes of poor integrity (p< 0.001) and PIVC
securement (p< 0.001) were statistically significant depending on the hospital environments.
However, there were no statically significant differences between dressing type (p = 0.200) and
causes of poor integrity (p = 0.068) comparing the hospital types.
The most frequent type of intravenous infusion was intermittent (263/646, 40.7%). We
identified 55/646 (8.5%) PIVCs without infusion in the last 24 hours and 58/646 (9.0%) PIVCs
without infusion for more than 24 hours. There were statistically significant differences
Table 4. (Continued)
Variables Overall Hospital types Hospital environments
Hospital 1 Hospital 2 Hospital 3 p-value Medical ward Surgical ward p-value
No 415
(64.2)
159 (57.4) 139 (65.9) 117 (74.1) 262 (65.7) 153 (61.9)
Yes 231
(35.8)
118 (42.6) 72 (34.1) 41 (25.9) 137 (34.3) 94 (38.1)
Infusion type, n (%) < 0.001 0.141
Continuous infusion 233
(36.1)
80 (28.9) 76 (36.0) 77 (48.7) 141 (35.3) 92 (37.2)
Intermittent Infusion 263
(40.7)
127 (45.8) 76 (36.0) 60 (38.0) 171 (42.9) 92 (37.2)
In bolus 37 (5.7) 18 (6.5) 18 (8.5) 1 (0.6) 27 (6.8) 10 (4.0)
No infusion in less than 24 h 55 (8.5) 16 (5.8) 23 (10.9) 16 (10.1) 29 (4.5) 26 (10.5)
No infusion for more than 24 h 58 (9.0) 36 (13.0) 18 (8.5) 4 (2.5) 31 (7.8) 27 (10.9)
PIVC failure, n (%) 0.031 0.086
No 364
(56.3)
142 (51.3) 117 (55.4) 105 (66.4) 237 (59.4) 127 (51.4)
Yes 74 (11.5) 32 (11.5) 28 (13.3) 14 (8.9) 46 (11.5) 28 (11.3)
Unevaluated 208
(32.2)
103 (37.2) 66 (31.3) 39 (24.7) 116 (29.1) 92 (37.1)
Presence of adverse event during visual inspection, n (%) 0.019 0.066
Persistent pain 29 (4.5) 10 (3.6) 13 (6.2) 6 (3.8) 15 (3.8) 14 (5.7)
Erythema 41 (6.3) 22 (7.9) 11 (5.2) 8 (5.1) 28 (7.0) 13 (5.3)
Palpable thrombosis 3 (0.5) 0 3 (1.4) 0 3 (0.7) 0
Deep venous thrombosis 0 0 0 0 0 0
Not defined 1 (0.2) 0 1 (0.5) 0 0 1 (0.4)
Presence of PIVC insertion records, n (%) < 0.001 < 0.001
No 338
(52.3)
220 (79.4) 105 (49.8) 13 (8.2) 170 (42.6) 168 (68.0)
Yes 308
(47.7)
57 (20.6) 106 (50.2) 45 (91.8) 229 (57.4) 79 (32.0)
Dressing date recorded, n (%) < 0.001 < 0.001
No 564
(87.3)
264 (95.3) 197 (93.4) 103 (65.2) 320 (80.2) 244 (98.8)
Yes 82 (12.7) 13 (4.7) 14 (6.6) 55 (34.8) 79 (19.8) 3 (1.2)
https://doi.org/10.1371/journal.pone.0240086.t004
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between the hospital types regarding the infusion type (p< 0.001). However, there were no
statically significant differences between this same outcome (p = 0.141) comparing the hospital
environments.
Concerning PIVC failure, 74 (11.5%) all adverse events identified were clinical of manifes-
tations of phlebitis. There were 29 episodes (4.5%) of persistent pain, 41 (6.3%) of erythema
and swelling around the insertion site, and 3 (0.5%) thrombosis. However, 208 PIVCs (32.2%)
could not be evaluated due to the presence of occlusive bandage. There were statically signifi-
cant differences between hospital types regarding PIVC failure (p = 0.031) and the occurrence
of adverse events (p = 0.019).
Less than 50% of nurses documented all information about PIVC insertion on the patient’s
clinical history (308/646, 47.7%). As for the recording of dressing dates, only 82/646 (12.7%)
were documented on the transparent dressings. We observed a higher rate of PIVC insertion
and dressing date records in medical wards (229/399; 57.4% and 79/399; 19.8% respectively)
than in surgical wards (79/247; 32% and 3/247; 1.2% respectively). We observed a statistically
significant association between hospital types and environments comparing the presence of
PIVC insertion recording (p< 0.001) and dressing date (p< 0.001).
Discussion
Our study focused on analysing the indicators from international CPG recommendations for
the insertion, management, and care of PIVC comparing hospital types and environments. This
study allowed us to map the baseline of the clinical outcomes for the implementation of these
recommendations into clinical practice. The findings related to dressing status, visual inspec-
tion, and unnecessary PIVCs were moderate. International evidence recommends that PIVC
dressings should be intact, clean, and dry, plus adequately secured and visible during the inspec-
tion of insertion site for prevention of PIVC failure [29–31]. The 34% of transparent dressings
were not in optimal conditions, a rate comparable to the 21–34% of dressings compromised
(moist, soiled, inadequately secured, or lifting of the skin) reported previously [1, 32]. An opti-
mum dressing should reduce multiple complications of PIVCs, such as extravasation or dis-
lodgement due to micromotions of the PIVC within the vein. Also, the poor dressing status
may cause the colonization of microorganisms, such as S. aureus, which can lead to severe com-
plications and death [33]. In our study, we observed that approximately 45% of PIVC insertion
sites were not visible, a disappointing scenario considering the impact that inspection of the
PIVC insertion site per shift would have to prevent and mitigate adverse events [31]. Removal
of the PIVC should occur if phlebitis, inflammation or obstruction are present, or intravenous
therapy has completed in the previous 24 hours, or the PIVC is no longer needed [4, 23, 34].
However, 9% of total PIVCs were unnecessarily maintained, with no differences between these
outcomes and the hospital environment. These results provide insight into the various mecha-
nisms that lead to PIVC failure, reflecting a poor adherence to recommendations with associ-
ated iatrogenic harms to patients [35]. PIVC failure triggers the need for a new PIVC insertion
with its potential adverse events, increasing the risk of CRBSIs [4], as well as imposing a signifi-
cant demand on healthcare resources [36, 37]. We observed suboptimal performance between
different hospital environments and types regarding the clinical outcomes from CPG recom-
mendations for care of PIVC. However, information regarding the use and knowledge of evi-
dence, the level of burnout or dissatisfaction, the level of workload within the unit, and/or
culture of implementation would be required to determine the conditions underlying this sub-
optimal performance concerning different environments [38].
From the point of view of safety and quality of care, healthcare organizations should
emphasize clinical implementation strategies [39] and delve deeper into their understanding
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of internal decision-making processes [40]. This strategy should incorporate mechanisms to
mediate knowledge into decision-making [41, 42], which is not only achieved through the
careful selection of evidence but also the weight of multiple humans factors [22]. Scientific evi-
dence should receive significant attention, but optimal decisions would require the integration
of such evidence with clinical experience together with patient involvement in shared deci-
sion-making [12, 43], shaping and coproducing practice "mindlines" [18, 41, 44, 45]. However,
we observed that almost 47.3% of patients did not know what a PIVC was. This finding reflects
a wide gap in patients’ knowledge regarding PIVC used in their care. Health literacy can be a
driver of change to empower patients in this self-care, being the initial hurdle to prevent and
monitor the development of complications and adverse events [46, 47]. Therefore, health liter-
acy of vascular access is a fundamental element that should be included within multimodal
interventions to improve catheter failure outcomes, patient empowerment in their self-care,
and shared decision making. Research efforts are needed to conduct this future education as
an improvement for patient and self-care of vascular access.
This study was essential to assess the clinical outcome indicators from CPG recommenda-
tions regarding the hospital environment as a baseline within a multimodal intervention [48].
We should integrate the best evidence while deepening the motivations and beliefs of health
professionals during decision-making for successful implementation, but we must also pay
attention to the context, the great neglected in the field of implementation science [49]. The
lack of context-related knowledge may be one of the most significant problems for implemen-
tation strategies into the healthcare system, being itself a fundamental limitation that questions
the efforts made to improve the quality of interventions and the fidelity on the use of evidence-
based practice [50]. The adaptation of interventions to local contexts is an indispensable ele-
ment in the science of implementation. However, it is frequently not explicitly considered how
local context factors determine its success [49]. In-depth knowledge of nurse participation in
hospital affairs, leadership, size of nursing teams and professional relationship, added to the
use, attitudes, and knowledge of professionals towards evidence-based practice will provide
relevant information about the contextual and individual mechanisms [51, 52] that can facili-
tate the integration of tacit and explicit knowledge into decision-making improving adherence
to best available recommendations [49, 53].
Our study presents some limitations. Our method could not include the evaluation of some
relevant practices that could influence the appearance of CRBSIs and PIVC failures, such as
the care of the patient’s catheter hub and connection port and using flush solutions to maintain
the permeability of PIVCs during evaluation. Future research must consider analysis and inte-
gration of contextual and individual factors on the use of best available knowledge in clinical
practice decisions to improve adherence to insertion and management recommendations of
PIVCs as a critical element to be considered within multimodal strategies for effective knowl-
edge mobilization [54, 55]. Also, these quality improvement initiatives for PIVC care should
include a set of relevant interventions consisting of the adequacy of the vascular access device,
optimal PIVC insertion care, maintenance and management of intravenous therapy, proactive
pursuit of opportunities for removing unnecessary PIVCs and health literacy of vascular
access. These actions would improve PIVC failure outcomes, sharing decision making, and
lead to significant cost savings for healthcare systems.
Conclusions
Our findings indicate that the clinical outcome indicators from CPG for the insertion, man-
agement, and maintenance associated with PIVC were moderate, highlighting differences
between hospital environments and types. Also, we observed that almost 50% of patients did
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not know what a PIVC is. These findings reflect a wide gap between knowledge and optimal
clinical practice, which would explain the moderate adherence to PIVC care and the need to
use a knowledge transfer model with contextual mechanisms and individual factors.
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